SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-010416
Filing Date
2022-05-20
Accepted
2022-05-20 16:56:06
Documents
12
Period of Report
2022-05-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K pali-20220520.htm   iXBRL 8-K 52039
  Complete submission text file 0000950170-22-010416.txt   169603

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20220520.xsd EX-101.SCH 2504
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20220520_pre.xml EX-101.PRE 10002
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20220520_lab.xml EX-101.LAB 13562
6 EXTRACTED XBRL INSTANCE DOCUMENT pali-20220520_htm.xml XML 4746
Mailing Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008
Business Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 22948473
SIC: 2836 Biological Products, (No Diagnostic Substances)